Deal will see hVivo manufacture virus for use in human challenge studies
Open Orphan subsidiary to manage Phase 2 clinical trial for European pharma company
Contract guarantees annual revenue for Dublin listed company
Company led by Cathal Friel recorded revenues of £7.1m for its first half
Paris subsidiary Venn Life Sciences to work with oncology study enrolling 750 subjects
Dublin listed company will carry out phase one trial at Hvivo facility
The pharmaceutical company has three months to acquire CHIMagents
Dublin-listed pharmaceutical services company publishes annual results for 2019
Agreement covers market access of newly developed medicine into EU and US markets
London subsidiary Hvivo will carry out testing at its lab with 48-hour turnaround
Challenge study models could speed up the development of a vaccine by up to three years
Antibody tests can detect if a person has had coronavirus before and has since recovered
Issues with everything from drug trials to tech solutions, patient care are being tackled
Pharma services company to build on an existing relationship with German company
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices